Mostrar el registro sencillo del ítem
Excitotoxicity as a target against neurodegenerative processes
dc.contributor.author | Binvignat O. | |
dc.contributor.author | Olloquequi J. | |
dc.date.accessioned | 2020-09-02T22:13:11Z | |
dc.date.available | 2020-09-02T22:13:11Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.2174/1381612826666200113162641 | |
dc.identifier.citation | 26, 12, 1251-1262 | |
dc.identifier.issn | 13816128 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3764 | |
dc.description | The global burden of neurodegenerative diseases is alarmingly increasing in parallel to the aging of population. Although the molecular mechanisms leading to neurodegeneration are not completely understood, excitotoxicity, defined as the injury and death of neurons due to excessive or prolonged exposure to excitatory amino acids, has been shown to play a pivotal role. The increased release and/or decreased uptake of glutamate results in dysregulation of neuronal calcium homeostasis, leading to oxidative stress, mitochondrial dysfunctions, disturbances in protein turn-over and neuroinflammation. Despite the anti-excitotoxic drug memantine has shown modest beneficial effects in some patients with dementia, to date, there is no effective treatment capable of halting or curing neurodegenerative diseases such as Alz-heimer’s disease, Parkinson disease, Huntington’s disease or amyotrophic lateral sclerosis. This has led to a grow-ing body of research focusing on understanding the mechanisms associated with the excitotoxic insult and on uncovering potential therapeutic strategies targeting these mechanisms. In the present review, we examine the molecular mechanisms related to excitotoxic cell death. Moreover, we provide a comprehensive and updated state of the art of preclinical and clinical investigations targeting excito-toxic-related mechanisms in order to provide an effective treatment against neurodegeneration. © 2020 Bentham Science Publishers. | |
dc.language.iso | en | |
dc.publisher | Bentham Science Publishers | |
dc.subject | Alzheimer’s disease | |
dc.subject | Calcium | |
dc.subject | ER stress | |
dc.subject | Glutamate | |
dc.subject | Neurodegeneration | |
dc.subject | Neuroinflammation | |
dc.subject | Oxidative stress | |
dc.subject | Parkinson’s disease | |
dc.subject | adenosine triphosphatase | |
dc.subject | amino acid | |
dc.subject | apoptosome | |
dc.subject | apoptotic protease activating factor 1 | |
dc.subject | BH3 protein | |
dc.subject | calcium | |
dc.subject | calcium channel blocking agent | |
dc.subject | calpain | |
dc.subject | caspase 9 | |
dc.subject | cinnarizine | |
dc.subject | DNA | |
dc.subject | flunarizine | |
dc.subject | glutamic acid | |
dc.subject | glyceraldehyde 3 phosphate dehydrogenase | |
dc.subject | inositol 1,4,5 trisphosphate receptor | |
dc.subject | ion channel | |
dc.subject | ionotropic receptor | |
dc.subject | isoflurane | |
dc.subject | lomerizine | |
dc.subject | memantine | |
dc.subject | n methyl dextro aspartic acid receptor | |
dc.subject | nimodipine | |
dc.subject | nitric oxide | |
dc.subject | propofol | |
dc.subject | reactive oxygen metabolite | |
dc.subject | reduced nicotinamide adenine dinucleotide phosphate oxidase | |
dc.subject | sodium calcium exchange protein | |
dc.subject | unindexed drug | |
dc.subject | verapamil | |
dc.subject | zonisamide | |
dc.subject | Alzheimer disease | |
dc.subject | amyotrophic lateral sclerosis | |
dc.subject | apoptosis | |
dc.subject | calcium homeostasis | |
dc.subject | cell death | |
dc.subject | cytotoxicity | |
dc.subject | degenerative disease | |
dc.subject | dementia | |
dc.subject | disease exacerbation | |
dc.subject | disorders of mitochondrial functions | |
dc.subject | DNA fragmentation | |
dc.subject | dopaminergic nerve cell | |
dc.subject | endoplasmic reticulum stress | |
dc.subject | excitotoxicity | |
dc.subject | frontotemporal dementia | |
dc.subject | human | |
dc.subject | Huntington chorea | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | inflammation | |
dc.subject | mitochondrial permeability | |
dc.subject | molecular mechanics | |
dc.subject | motor performance | |
dc.subject | nerve degeneration | |
dc.subject | nervous system inflammation | |
dc.subject | nitrosylation | |
dc.subject | oxidative stress | |
dc.subject | Parkinson disease | |
dc.subject | pathophysiology | |
dc.subject | priority journal | |
dc.subject | protein processing | |
dc.subject | Review | |
dc.subject | traumatic brain injury | |
dc.subject | unfolded protein response | |
dc.title | Excitotoxicity as a target against neurodegenerative processes | |
dc.type | Review |